Breaking News

Roquette Reorganizes into Two Business Groups

Following the acquisition of IFF Pharma Solutions, Roquette has created 2 complementary Business Groups: Health & Pharma Solutions and Nutrition & Bioindustry.

Roquette, a leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, has reorganized following the successful acquisition of IFF Pharma Solutions.

The new organization features two Business Groups that will rely on dedicated teams and assets to fully focus on meeting customer and market needs. Isabelle Bouvier is appointed as CEO of the Health & Pharma Solutions Business Group and Pascal Leroy as CEO of the Nutrition & Bioindustry Business Group. Béatrice Totel replaces Isabelle Bouvier as CFO of Roquette.

Pierre Courduroux, CEO of Roquette, said: “Building on our robust and integrated business model, Roquette is strengthening its organization by creating two well-balanced and complementary Business Groups. Each Business Group will be equipped with dedicated assets, capabilities, and teams to better serve our customers, all while continuing to operate under the strong Roquette brand.”

Health & Pharma Solutions Business Group

Roquette’s Health & Pharma Solutions Business Group helps address complex challenges in drug delivery and patient care. The creation of a dedicated team will allow the company to offer greater agility in its customer service and product development. The new Business Group aims to accelerate growth through innovation and service quality, further cementing Roquette’s leadership in the pharmaceutical and health sectors.

Isabelle Bouvier, who brings extensive corporate experience within international environments, is appointed to lead the Health & Pharma Solutions Business Group. Bouvier joined Roquette as Chief Financial Officer in 2021, also overseeing Digital, M&A and Strategy. As part of this role, she led the acquisition processes of both Qualicaps in 2023 and IFF Pharma Solutions, preparing the integration from the signing in March 2024.

Nutrition & Bioindustry Business Group

Following the acquisition, some of the business and product lines from IFF have now been integrated into Roquette’s Nutrition & Bioindustry Business Group, enhancing its expertise in food and selected industrial applications.

Pascal Leroy is appointed to lead the Nutrition & Bioindustry Business Group. Leroy joined Roquette over twelve years ago and has held various senior leadership positions within the company overseeing Commercial, Procurement, Quality and Supply Chain activities.

Chief Financial Officer

Following Isabelle Bouvier’s appointment, Béatrice Totel is now CFO of Roquette.

Since joining the company in 2021 as Head of Business Finance, Totel has played a pivotal role in shaping Roquette’s business finance strategy and operations. Her extensive experience in key financial roles within multinational industrial companies has equipped her with business acumen and a track record in finance leadership. Her expertise will ensure a smooth transition and continuity within the organization.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters